Confessions of a Quackbuster

This blog deals with healthcare consumer protection, and is therefore about quackery, healthfraud, chiropractic, and other forms of so-Called "Alternative" Medicine (sCAM).

Tuesday, December 06, 2005

Economics of vaccination

Economic Evaluation of the 7-Vaccine Routine Childhood Immunization Schedule in the United States, 2001

Fangjun Zhou, PhD; Jeanne Santoli, MD, MPH; Mark L. Messonnier, PhD; Hussain R. Yusuf, MBBS, MPH; Abigail Shefer, MD; Susan Y. Chu, PhD, MSPH; Lance Rodewald, MD; Rafael Harpaz, MD, MPH

Arch Pediatr Adolesc Med. 2005;159:1136-1144.

To evaluate the economic impact of the routine US childhood immunization schedule: diphtheria and tetanus toxoids and acellular pertussis; tetanus and diphtheria toxoids; Haemophilus influenzae type b conjugate; inactivated poliovirus; measles, mumps, and rubella; hepatitis B; and varicella vaccines.

Decision tree-based analysis was conducted using population-based vaccination coverage, published vaccine efficacies, historical data on disease incidence before vaccination, and disease incidence reported for 1995-2001. Costs were estimated using the direct cost and societal (direct and indirect costs) perspectives. Program costs included vaccine, administration, vaccine-associated adverse events, and parent travel and time lost. All costs were inflated to 2001 US dollars, and all costs and benefits in the future were discounted at a 3% annual rate.

A hypothetical 2001 US birth cohort of 3 803 295 infants was followed up from birth through death.

Main Outcome Measures
Net present value (net savings) and benefit-cost ratios of routine immunization.

Routine childhood immunization with the 7 vaccines was cost saving from the direct cost and societal perspectives, with net savings of $9.9 billion and $43.3 billion, respectively. Without routine vaccination, direct and societal costs of diphtheria, tetanus, pertussis, H influenzae type b, poliomyelitis, measles, mumps, rubella, congenital rubella syndrome, hepatitis B, and varicella would be $12.3 billion and $46.6 billion, respectively. Direct and societal costs for the vaccination program were an estimated $2.3 billion and $2.8 billion, respectively. Direct and societal benefit-cost ratios for routine childhood vaccination were 5.3 and 16.5, respectively.

Regardless of the perspective, the current routine childhood immunization schedule results in substantial cost savings.

Author Affiliations:
National Immunization Program, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, Ga. Dr Yusuf is now with UNICEF, New Delhi, India.

********************** Subscribe to this blog **********************
Enter your email address below to subscribe to
Confessions of a Quackbuster!

powered by Bloglet

Reciprocal Links: An Invitation